ArticleCase reports in gastrointestinal medicine2026
Pyoderma Gangrenosum as the First Manifestation of Inflammatory Bowel Disease: A Case Report.
Article in Case reports in gastrointestinal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pyoderma Gangrenosum as the First Manifestation of Inflammatory Bowel Disease: A Case Report.Case reports in gastrointestinal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Approximately 50% of patients with inflammatory bowel disease (IBD) exhibit extraintestinal manifestations, among which skin and mucosal lesions are common. However, pyoderma gangrenosum occurs in only 1%-2% of IBD patients. We report the case of a 23-year-old male patient who was admitted to the hospital with pyoderma gangrenosum that was unresponsive to conventional treatments. The patient did not exhibit any gastrointestinal symptoms. We conducted diagnostic investigations, excluding causes such as infections, vascular occlusions, and systemic diseases. The patient did not respond to systemic antibiotic therapy and local care. With mild thickening of the colon wall observed on a CT scan, we decided to perform a colonoscopy, which revealed lesions suggestive of chronic ulcerative colitis. Histopathological examination of the colon tissue confirmed the diagnosis. With the diagnosis of early onset chronic ulcerative colitis presenting with extraintestinal manifestations, we decided to treat the patient with the biological drug infliximab. After 3 months of treatment, the pyoderma gangrenosum lesions healed. In summary, this clinical case indicates that pyoderma gangrenosum can be an initial and rare manifestation of IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.